Tryptophan metabolism mediated by IDO1 generates biologically active kynurenine pathway metabolites, leading to differentiation and/or activation of FoxP3-expressing regulatory T cells (Treg), to suppression of anti-tumour T-cell responses and to reduced dendritic cell (DC) immunogenicity [2,3]. Here, IDO1 is linked to neoplasm.